THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT04436653

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04436653
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04436653. Allocation not applicable; no masking; primary purpose treatment. Start 2020-06-16 (actual); primary completion 2026-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve
Acronym
TRAVEL
Condition
Tricuspid Valve Insufficiency
Intervention (Device)
Tricuspid Valve Replacement System
Lead sponsor
Changhai Hospital (class: other)
Collaborator
Fu Wai Hospital, Beijing, China (class: other)
Collaborator
Beijing Anzhen Hospital (class: other)
Collaborator
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (class: other)
Collaborator
West China Hospital (class: other)
Collaborator
Xijing Hospital (class: other)
Collaborator
Guangdong Provincial People's Hospital (class: other)
Collaborator
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)

Record details

Record id
cardio:ct-nct04436653
Content hash
d5c7703403ca369ceec32614d05b7cf63fcbe6dbb41fef43a9a41a4420900905